DE69824901D1 - Cholesterin Esterase Inhibitoren - Google Patents

Cholesterin Esterase Inhibitoren

Info

Publication number
DE69824901D1
DE69824901D1 DE69824901T DE69824901T DE69824901D1 DE 69824901 D1 DE69824901 D1 DE 69824901D1 DE 69824901 T DE69824901 T DE 69824901T DE 69824901 T DE69824901 T DE 69824901T DE 69824901 D1 DE69824901 D1 DE 69824901D1
Authority
DE
Germany
Prior art keywords
cholesterol esterase
esterase inhibitors
inhibitors
cholesterol
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69824901T
Other languages
English (en)
Inventor
Lorraine Deck
Jagt David L Vander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of New Mexico UNM
Original Assignee
University of New Mexico UNM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of New Mexico UNM filed Critical University of New Mexico UNM
Application granted granted Critical
Publication of DE69824901D1 publication Critical patent/DE69824901D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69824901T 1997-04-16 1998-04-15 Cholesterin Esterase Inhibitoren Expired - Lifetime DE69824901D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4198897P 1997-04-16 1997-04-16

Publications (1)

Publication Number Publication Date
DE69824901D1 true DE69824901D1 (de) 2004-08-05

Family

ID=21919442

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69819482T Expired - Fee Related DE69819482T2 (de) 1997-04-16 1998-04-15 Inhibitoren der cholesterolesterase
DE69824901T Expired - Lifetime DE69824901D1 (de) 1997-04-16 1998-04-15 Cholesterin Esterase Inhibitoren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69819482T Expired - Fee Related DE69819482T2 (de) 1997-04-16 1998-04-15 Inhibitoren der cholesterolesterase

Country Status (7)

Country Link
US (3) US5942631A (de)
EP (1) EP0975617B1 (de)
JP (1) JP2002512611A (de)
AT (2) ATE253565T1 (de)
CA (1) CA2284525A1 (de)
DE (2) DE69819482T2 (de)
WO (1) WO1998046585A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115279B2 (en) * 2000-08-03 2006-10-03 Curatolo William J Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
WO2009086096A2 (en) * 2007-12-21 2009-07-09 University Of Cincinnati Therapeutic use of carboxyl ester lipase inhibitors
US9061796B2 (en) * 2009-04-23 2015-06-23 H.J. Heinz Company Multi-function condiment container
EP2844303B1 (de) 2012-05-03 2021-09-15 Beth Israel Deaconess Medical Center, Inc. Lipide zur erhöhung der insulinempfindlichkeit und verfahren zur verwendung davon
WO2014144777A2 (en) 2013-03-15 2014-09-18 Beth Israel Deaconess Medical Center, Inc. Lipids that increase insulin sensitivity and methods of using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3056802A (en) * 1960-10-04 1962-10-02 Union Carbide Corp Alpha-halo lactones
US3227736A (en) * 1962-10-31 1966-01-04 Olin Mathieson Production of alpha-fluorocarboxylic acids and esters
US3346594A (en) * 1965-08-25 1967-10-10 Gen Aniline & Film Corp Haloalkyl and polyhaloalkyl lactones
US4338122A (en) * 1979-09-26 1982-07-06 Union Carbide Corporation Biocidal 2-aryl-1,3-cyclopentanedione compounds and alkali metal and ammonium salts thereof
GB2168696B (en) * 1984-12-21 1989-01-11 Boehringer Biochemia Srl Fluoro coumarins as antilymphoedema agents
US5025017A (en) * 1989-09-28 1991-06-18 E. R. Squibb & Sons, Inc. Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates
US5059696A (en) * 1990-03-15 1991-10-22 Merck & Co., Inc. Processes and intermediates for the preparation of 5-oxygenated hmg-coa reductase inhibitors
GB9100174D0 (en) * 1991-01-04 1991-02-20 British Bio Technology Compounds
JP3159990B2 (ja) * 1992-11-18 2001-04-23 フイルメニツヒ ソシエテ アノニム 香料成分としてのフラノンの使用
FR2741620B1 (fr) * 1995-11-28 1997-12-26 Oreal Procede de preparation de composes a groupement beta-hydroxy -delta-lactone analogues de la (+) compactine et de la (+) mevinoline

Also Published As

Publication number Publication date
CA2284525A1 (en) 1998-10-22
US6114545A (en) 2000-09-05
DE69819482D1 (de) 2003-12-11
DE69819482T2 (de) 2004-08-26
ATE253565T1 (de) 2003-11-15
US5942631A (en) 1999-08-24
US6034255A (en) 2000-03-07
EP0975617A4 (de) 2000-09-13
WO1998046585A1 (en) 1998-10-22
ATE270284T1 (de) 2004-07-15
EP0975617B1 (de) 2003-11-05
EP0975617A1 (de) 2000-02-02
JP2002512611A (ja) 2002-04-23

Similar Documents

Publication Publication Date Title
IS4695A (is) (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem sýklóoxýgenasa-2 tálmar
ID18143A (id) Penghambat metaloprotease amina siklik tersubstitusi
DK0840732T3 (da) Substituerede benzolactamforbindelser som substans P-antagonister
DE69816280D1 (de) Inhibitoren des impdh-enzyms
YU35802A (sh) Polimorfni oblik atorvastatin kalcijuma
NO20020214L (no) Substituerte oksoazaheterocyklylforbindelser
ATE277929T1 (de) Immunsuppressive wirkungen von pteridinderivaten
MX9702865A (es) Agentes estrogenicos.
ATE308327T1 (de) Verwendung von 2-hydroxy-5-phenylazobenzoesäure- derivaten als wirkstoffe zur chemoprävention und chemotherapie von kolonkrebs
BR9811099A (pt) Inibidores de urocinase
DK1001761T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsunderskudslidelser
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
BR0014990A (pt) Derivados de tetrahidrotiopirano ranftalazinona como inibidores de pde4
CA2266759A1 (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
SE9801494D0 (sv) Novel use
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
DE69824901D1 (de) Cholesterin Esterase Inhibitoren
FI950842A (fi) Enkefalinaasin inhibiittoreina käyttökelpoisia uusia 2-substituoituja trisyklisiä indaani-2-merkaptoasetyyliamidijohdannaisia
ES2147973T3 (es) Estirenos alquilatados como profarmacos de inhibidores de cox-2.
ES2188908T3 (es) Derivados de cis-3,4-cromano utiles para la prevencion o tratamiento de sindromes relacionados con el estrogenos.
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
MXPA01006469A (es) Combinaciones de inhibidores de proteina de transferencia de ester colesterilico y derivados de acido fibrico para indicaciones cardiovasculares.
FR2791982B1 (fr) Inhibiteurs de lta4 hydrolase et leurs applications therapeutiques.
ES2191170T3 (es) Nuevos (-)-enantiomeros de derivados de cis-3,4-cromano utiles en la prevencion y tratamiento de sindromes o enfermedades relacionadas con el estrogeno.
NO912985D0 (no) Forbedret system for transdermal applikasjon av farmasoeytisk aktive forbindelser ved regulert ph.

Legal Events

Date Code Title Description
8332 No legal effect for de